Currently, the FDA approves only one medication specifically for treating hypoactive sexual desire disorder (HSDD) in premenopausal women: flibanserin (Addyi).
Understanding Addyi is key. It’s a non-hormonal medication, working differently than Viagra. It affects brain neurotransmitters, potentially increasing sexual desire. However, it carries side effects, including dizziness and nausea. Your doctor will assess your suitability.
- Important Note: Addyi requires a careful discussion with your doctor. It interacts with other medications, like alcohol, requiring strict adherence to usage guidelines. Off-label Prescriptions: While not FDA-approved for female sexual dysfunction, some doctors may prescribe other medications off-label. This always requires careful consideration of benefits versus potential risks. These discussions are vital before proceeding.
Beyond medication, consider these options:
Therapy: Counseling, particularly sex therapy, can address psychological factors contributing to sexual dysfunction. This involves exploring relationship dynamics, body image issues, and anxieties that may impact sexual response. Lifestyle Changes: Addressing underlying health conditions like diabetes or cardiovascular disease can positively impact sexual function. Managing stress levels through relaxation techniques is also beneficial. Medical Devices: Certain devices, although not FDA-approved for all aspects of female sexual dysfunction, may be recommended by your healthcare provider for specific issues.
Remember, open communication with your doctor is paramount. They can conduct a thorough evaluation, discuss your medical history, and recommend the most suitable treatment plan based on your individual needs. This approach ensures you receive appropriate care and accurate information.
